tradingkey.logo
tradingkey.logo
Search

LENSAR Inc

LNSR
Add to Watchlist
5.840USD
+0.130+2.28%
Close 07/01, 16:00ETQuotes delayed by 15 min
71.72MMarket Cap
2.39P/E TTM

More Details of LENSAR Inc Company

LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The Company has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.

LENSAR Inc Info

Ticker SymbolLNSR
Company nameLENSAR Inc
IPO dateSep 21, 2020
CEOCurtis (Nicholas T)
Number of employees140
Security typeOrdinary Share
Fiscal year-endSep 21
Address2800 Discovery Drive
CityORLANDO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code32826
Phone18885367271
Websitehttps://www.lensar.com/
Ticker SymbolLNSR
IPO dateSep 21, 2020
CEOCurtis (Nicholas T)

Company Executives of LENSAR Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Nicholas T. (Nick) Curtis
Mr. Nicholas T. (Nick) Curtis
Chief Executive Officer, Director
Chief Executive Officer, Director
855.10K
--
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
550.64K
--
Dr. Richard L. Lindstrom, M.D.
Dr. Richard L. Lindstrom, M.D.
Independent Director
Independent Director
246.41K
--
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
92.95K
--
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
88.21K
--
Mr. Alan B. Connaughton
Mr. Alan B. Connaughton
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Thomas R. Staab, II
Mr. Thomas R. Staab, II
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Ms. Elizabeth G. O'Farrell
Ms. Elizabeth G. O'Farrell
Independent Director
Independent Director
--
--
Mr. Thomas B. Ellis
Mr. Thomas B. Ellis
Independent Director
Independent Director
--
--
Mr. Todd B. Hammer
Mr. Todd B. Hammer
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Nicholas T. (Nick) Curtis
Mr. Nicholas T. (Nick) Curtis
Chief Executive Officer, Director
Chief Executive Officer, Director
855.10K
--
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
550.64K
--
Dr. Richard L. Lindstrom, M.D.
Dr. Richard L. Lindstrom, M.D.
Independent Director
Independent Director
246.41K
--
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
92.95K
--
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
88.21K
--
Mr. Alan B. Connaughton
Mr. Alan B. Connaughton
Chief Operating Officer
Chief Operating Officer
--
--

FAQs

Who are the top five shareholders of LENSAR Inc?

The top five shareholders of LENSAR Inc are: Mr. Nicholas T. (Nick) Curtis

How many institutions hold shares of LENSAR Inc (LNSR)?

As of 2026Q1, 172 institutions hold shares of LENSAR Inc, with a combined market value of approximately 6.68M, accounting for 55.41% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -342758.00.